This correlation between tumor grade and E-cadherin expression was also discussed in a 2013 study by Koyuncuoglu et al., which found that 20% of Grade 1 tumors, 40% of Grade 2 tumors, and 72% of Grade 3 tumors showed decreased E-cadherin expression [17]. The gene discussed is CDH1; the disease is neoplasm.